featured
Three-Year Outcomes of Individualized Ranibizumab in Diabetic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients With Diabetic Macular Edema: The RESTORE Extension Study
Ophthalmology 2014 Feb 01;[EPub Ahead of Print], U Schmidt-Erfurth, GE Lang, FG Holz, RO Schlingemann, P Lanzetta, P Massin, O Gerstner, AS Bouazza, H Shen, A Osborne, P MitchellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.